Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN)
CAPS Rating:
A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.
A biotechnology company working to develop and deliver life-changing drug therapies for patients with serious and life-threatening medical conditions.
Recs
everyone loves this stock. It wasn't just added to the S&P 500 for no reason. Earnings, Sales, ROE are all exceptional. Created a niche market for rare diseases and management will continue to outperform expectations.